Filter by: patients

Treatments Reported by Patients with HIV (Human Immunodeficiency Virus)

36.2% of the 3,110 patients with HIV (Human Immunodeficiency Virus) report taking at least one of these treatments to modify their disease or manage its symptoms.

Treatment # Patients
Efavirenz-Emtricitabine-Tenofovir (Atripla) 440 14% Efavirenz-Emtricitabine-Tenofovir (Atripla): 14%
Emtricitabine-Tenofovir (Truvada) 343 11% Emtricitabine-Tenofovir (Truvada): 11%
Ritonavir (Norvir) 248 8% Ritonavir (Norvir): 8%
Atazanavir (Reyataz) 155 5% Atazanavir (Reyataz): 5%
raltegravir (Isentress) 139 4% raltegravir (Isentress): 4%
Abacavir-Lamivudine (Epzicom, Kivexa) 119 4% Abacavir-Lamivudine (Epzicom, Kivexa): 4%
Darunavir (Prezista) 100 3% Darunavir (Prezista): 3%
Efavirenz (Sustiva, Stocrin) 82 3% Efavirenz (Sustiva, Stocrin): 3%
Nevirapine (Viramune) 82 3% Nevirapine (Viramune): 3%
Tenofovir (Viread) 78 3% Tenofovir (Viread): 3%
Abacavir-lamivudine-zidovudine (Trizivir) 26 1% Abacavir-lamivudine-zidovudine (Trizivir): 1%

Community Treatment Reports

Click on a treatment to see what patients with HIV (Human Immunodeficiency Virus) have to say about side-effects, efficacy, advice, burden, dosages and cost of any treatment they're taking for any condition.